Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

DEN1 protein, Aspergillus nidulans

 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

EndopeptidasesFungal Proteins

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Preclinical development of a dengue tetravalent recombinant subunit vaccine: Immunogenicity and protective efficacy in nonhuman primates.
We describe here the preclinical development of a dengue vaccine composed of recombinant subunit carboxy-truncated envelope (E… Expand
  • table 1
  • figure 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2015
2015
Development of a capillary zone electrophoresis method for dose determination in a tetravalent dengue vaccine candidate.
Dengue is known to cause morbidity and mortality worldwide and currently there is neither available specific therapeutics to… Expand
Is this relevant?
Review
2015
Review
2015
Preclinical and clinical development of a dengue recombinant subunit vaccine.
This review focuses on a dengue virus (DENV) vaccine candidate based on a recombinant subunit approach which targets the DENV… Expand
Is this relevant?
2007
2007
Prof. Dr. phil. Bruno Schulze 65 Jahre
s .%." c h u I z e wurde ~ m 8J anunr 1 $99 in Berlin geboren. Hier ist (r aufgewachsen und ha t er naeb dem Abi tu r und einer… Expand
Is this relevant?
Highly Cited
2001
Highly Cited
2001
Construction, safety, and immunogenicity in nonhuman primates of a chimeric yellow fever-dengue virus tetravalent vaccine.
We previously reported construction of a chimeric yellow fever-dengue type 2 virus (YF/DEN2) and determined its safety and… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE